<DOC>
	<DOCNO>NCT00501423</DOCNO>
	<brief_summary>The ADRIE study observational study clinical relevance platelet reactivity aspirin clopidogrel treat cardiovascular patient .</brief_summary>
	<brief_title>Antiplatelet Drug Resistances Ischemic Events</brief_title>
	<detailed_description>The ADRIE study observational study clinical relevance platelet reactivity aspirin clopidogrel treat cardiovascular patient . Main objective : - determine platelet reactivity , assess specific non-specific test , predictive ischemic event 3-year follow-up . Secondary objective : - primary outcome pre-specified sub-group : patient coronary artery disease , ischemic stroke peripheral arterial disease main qualify disease entry , - determine platelet reactivity , assess specific non-specific test , predictive bleed event 3-year follow-up , - investigate potential determinant platelet reactivity entry study</detailed_description>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>Documented symptomatic ischemic atherothrombotic disease treat aspirin , clopidogrel . Known platelet disorder Chronic treatment antiplatelet drug aspirin clopidogrel . Chronic anticoagulant treatment Chronic non steroid anti inflammatory drug treatment Active cancer Ongoing aspirin clopidogrel treatment take 5 year prior inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>antiplatelet drug</keyword>
	<keyword>resistance</keyword>
	<keyword>atherothrombosis</keyword>
</DOC>